Global leader in cellular imaging unveils latest imaging and analysis software platform with new measurement capabilities for better understanding of intercellular and intracellular relationships
The Volocity software features a suite of high performance tools for exploring, interacting and publishing 3D imaging data from cells, tissues and organisms and how they behave over time - for greater insights and knowledge into cellular interactions. The software is designed as a universal solution that provides users with significant functionality to visualize, analyze and validate 3D fluorescence images from a wide range of confocal microscopy, wide-field and high content screening systems, and is fully integrated for a seamless user experience.
"PerkinElmer is committed to supporting new discoveries that will ultimately lead to new treatments in disease research fields such as cancer and neurodegeneration," said Achim von Leoprechting, vice president, Imaging and Detection Solutions, Bio-discovery, PerkinElmer. "Through new applications and enhanced imaging capabilities, the new Volocity 6.0 software will help scientists better understand how diseases affect cells as well as how potential therapies affect diseased and healthy cells."
Beyond simple cells, the Volocity software can also organize and relate measurements according to biological classification such as nuclei, membranes, organelles, and proteins, making it easier and faster to perform an analysis and understand the results. The updated interface also enables users of all skill levels to perform complex and challenging biological measurements, thereby extending the power of 3D analysis to a wider population of potential users.
Key new features of the Volocity 6.0 suite enable end-users to:
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
Edelman (on behalf of PerkinElmer, Inc.)
Source: PerkinElmer, Inc.
News Provided by Acquire Media